RC
GMED icon

Roundview Capital’s Globus Medical GMED Stock Holding History

Roundview Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,262
Closed -$416K – 337
2025
Q3 		$416K Buy
+7,262
New +$418K 0.03% 276
2024
Q4 		– Sell
-7,833
Closed -$560K – 337
2024
Q3 		$560K Buy
7,833
+103
+1% +$7.27K 0.04% 260
2024
Q2 		$529K Sell
7,730
-29
-0.4% -$1.73K 0.04% 251
2024
Q1 		$416K Buy
7,759
+1,300
+20% +$69.9K 0.03% 270
2023
Q4 		$344K Buy
6,459
+29
+0.5% +$1.41K 0.03% 272
2023
Q3 		$319K Buy
6,430
+984
+18% +$55K 0.03% 270
2023
Q2 		$324K Hold
5,446
– – 0.03% 267
2023
Q1 		$308K Hold
5,446
– – 0.03% 279
2022
Q4 		$404K Buy
+5,446
New +$371K 0.05% 242
2022
Q2 		– Sell
-3,278
Closed -$242K – 284
2022
Q1 		$242K Sell
3,278
-7,262
-69% -$505K 0.02% 275
2021
Q4 		$761K Hold
10,540
– – 0.08% 215
2021
Q3 		$808K Hold
10,540
– – 0.09% 201
2021
Q2 		$817K Buy
+10,540
New +$749K 0.09% 206

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Roundview Capital's GMED Position: Q4 2025 in Review

Roundview Capital sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 7,262 shares — an estimated $416K sold.

Roundview Capital first reported a position in GMED in Q2 2021 and held it in 13 quarters. The position peaked at $817K in Q2 2021. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Roundview Capital reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Roundview Capital sold 7,262 Globus Medical shares in Q4 2025, an estimated $416K.
  • Roundview Capital first reported a position in Globus Medical in Q2 2021 and held it in 13 quarters.
  • Roundview Capital's Globus Medical position peaked at $817K in Q2 2021.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Roundview Capital's 13F filing for Q4 2025, filed 9 Feb 2026.